Literature DB >> 2508261

Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.

P M Mannucci1, M Colombo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2508261

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  2 in total

1.  Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII C.

Authors:  J M Lusher
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

2.  Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors.

Authors:  Hussain I Saba; Duc Quang Tran
Journal:  J Blood Med       Date:  2011-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.